人工智能与机器学习在精准肿瘤学中的应用:多组学整合提升可发现性的综述
本文综述多组学数据(含影像组学与分子标志物)在精准肿瘤学诊断与治疗中的角色,介绍人工智能与机器学习的数据融合、建模及验证方法,展示多组学研究在肿瘤中的应用实例,并讨论数据集异质性、组学数据可及性与研究验证等挑战。
要点
- 多组学数据包括影像组学和多种分子标志物,可用于肿瘤诊断与治疗研究。
- 人工智能与机器学习结合多组学数据可能革新肿瘤亚型划分、风险分层、预后预测与临床决策。
- 多组学研究向临床转化需标准化数据收集分析、建设数据共享存储基础设施、改进融合与可解释性并开展大规模前瞻性临床试验。
核心结论
- 人工智能与机器学习结合多组学数据在精准肿瘤学中具有革新肿瘤亚型划分、风险分层、预后预测和临床决策的潜力,但向临床转化仍需在数据标准化、计算基础设施、融合方法与可解释性以及大规模前瞻性临床试验方面持续努力。
研究设计与样本
- 综述:介绍多组学数据类别及其在诊断与治疗中的作用,阐述基于人工智能的数据融合方法与建模方法及不同验证方案,展示多组学研究在肿瘤中的应用与实例,并讨论相关挑战。
局限性
- 数据集存在异质性。
- 组学数据的可及性受限。
- 研究的验证存在挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Multiomics data including imaging radiomics and various types of molecular biomarkers have been increasingly investigated for better diagnosis and therapy in the era of precision oncology. Artificial intelligence (AI) including machine learning (ML) and deep learning (DL) techniques combined with the exponential growth of multiomics data may have great potential to revolutionize cancer subtyping, risk stratification, prognostication, prediction and clinical decision-making. In this article, we first present different categories of multiomics data and their roles in diagnosis and therapy. Second, AI-based data fusion methods and modeling methods as well as different validation schemes are illustrated. Third, the applications and examples of multiomics research in oncology are demonstrated. Finally, the challenges regarding the heterogeneity data set, availability of omics data, and validation of the research are discussed. The transition of multiomics research to real clinics still requires consistent efforts in standardizing omics data collection and analysis, building computational infrastructure for data sharing and storing, developing advanced methods to improve data fusion and interpretability, and ultimately, conducting large-scale prospective clinical trials to fill the gap between study findings and clinical benefits.
引用
- Wei L, Niraula D, Gates EDH, et al. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration. Br J Radiol. 2023. PMID: 37660402. doi:10.1259/bjr.20230211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。